Atlas Trials

Ombitasvir/ Paritaprevir / Ritonavir Plus Ribavirin in Management HCV and End-stage Kidney Disease

Clinical trial NCT03499639 · COMPLETED

Trial details

NCT number
NCT03499639
Sponsor
Assiut University
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
End-stage Renal DiseaseHCV Coinfection
Start date
2018-05-01
Primary completion
2018-08-01
Enrollment
110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.